1. Home
  2. SVAQ vs ARCT Comparison

SVAQ vs ARCT Comparison

Compare SVAQ & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVAQ

Silicon Valley Acquisition Corp. Class A Ordinary Shares

N/A

Current Price

$9.95

Market Cap

291.7M

Sector

Finance

ML Signal

N/A

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$7.03

Market Cap

245.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVAQ
ARCT
Founded
2025
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
291.7M
245.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SVAQ
ARCT
Price
$9.95
$7.03
Analyst Decision
Buy
Analyst Count
0
10
Target Price
N/A
$24.11
AVG Volume (30 Days)
32.9K
402.0K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
N/A
$82,031,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$12.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.86
$5.85
52 Week High
$9.96
$24.14

Technical Indicators

Market Signals
Indicator
SVAQ
ARCT
Relative Strength Index (RSI) 58.75 37.07
Support Level $9.91 $6.90
Resistance Level N/A $7.88
Average True Range (ATR) 0.01 0.61
MACD 0.00 -0.21
Stochastic Oscillator 87.50 12.86

Price Performance

Historical Comparison
SVAQ
ARCT

About SVAQ Silicon Valley Acquisition Corp. Class A Ordinary Shares

Silicon Valley Acquisition Corp is a blank check company.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: